+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Peptides. Challenges and Future Perspectives

  • Book

  • November 2022
  • Elsevier Science and Technology
  • ID: 5483870

Antimicrobial Peptides: Challenges and Future Perspectives covers the latest developments about antimicrobial peptides in the scenario of drug resistance. The book is divided into 16 chapters arranged in sequence and preceded by chapters on historical developments and their role as regulatory molecules in innate defense mechanism. Emphasis is given to purification techniques and characterization suitable for interdisciplinary research. Chapters provide an inventory of various antimicrobial peptides, from a diverse array of organisms such as bacteria, fungi, insects, amphibians, plants and mammals. A section on marine ecosystem broadens readers understanding on marine based antimicrobial peptides.

Additional sections provide an informative overview on peptides with antiviral properties and those targeting multi-drug resistant bacteria. Recent reports and mechanism on resistance against antimicrobial peptides are also provided, along with key insights into the challenges and future perspectives of peptide drug development.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Historical developments of antimicrobial peptide research
2. Biosynthesis of peptide antibiotics and innate immunity
3. Antimicrobial peptides: features and mode of action
4. Purification techniques and characterisation of antimicrobial peptides
5. Peptide antibiotics from bacteria
6. Antimicrobial peptides of fungal origin
7. Insect peptides with antimicrobial effect
8. Amphibian host defence peptides
9. Plant derived antimicrobial peptides
10. Mammalian antimicrobial peptides
11. Antimicrobial peptides from marine environment
12. Peptides with antiviral activities
13. Peptide antibiotics against MDR bacteria
14. Antimicrobial peptide resistance
15. Recent advances and challenges in peptide drug development
16. Future perspective of peptide antibiotic market

Authors

K. Sreejith Professor, Department of Biotechnology and Microbiology, Kannur University, Kerala, India. He is also the Research Director of Kannur University since 2018. Dr. Sreejith has received MPhil in Biophysics and PhD in Biochemistry from Mahatma Gandhi University, Kerala, India. He has more than 19 years of teaching and research experience. His area of research is antimicrobial peptides and proteins, anti inflammatory compounds and cancer biology. Since 2008, his team has contributed extensively in the aforementioned area with publications appearing in the Journal of Applied Microbiology, Applied Biochemistry and Biotechnology, Peptides, Mycopathologia. He has presented papers in the II International conference on antimicrobial research, Lisbon, Portugal-2012 and European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), Amsterdam (Netherlands) in 2016. He is a life member of Indian Peptide Society (IPS). Since 2003 he has been serving Kannur University in its Board of studies in Microbiology as a member and from 2010 onwards he is the Chairman. He is having collaboration with researchers, Dr Sudarslal, Professor, School of Biotechnology, Amrita Vishwa Vidyapeetham, Kerala, India, and Dr C Arunan, School of Chemical Sciences, Mahatma Gandhi University, Kerala, India K. Ajesh Faculty, Department of Biotechnology and Microbiology, Kannur University, India. He has completed his masters in Microbiology from Kuvempu University, Karnataka, India and received PhD in Microbiology from Kannur University, Kerala India. His area of research is peptide antibiotics, biofilms, drug resistance and Phage therapy. He has more than five years of teaching and research experience. His contribution in antimicrobial peptides and drug resistance appeared in various journals including-peptides, Journal of Applied microbiology, Applied Biochemistry & Biotechnology, Mycopathologia. He has been Board of studies member in Microbiology (2014-18) and Chairman, Board of Examiners in Biotechnology and Microbiology (2012-15), Kannur University. He is a reviewer of Journal of Bacteriology and Mycology. He is a member of Indian Peptide Society (IPS), Indian Initiative for Management of Antibiotic Resistance (IIMAR) and International Society for Viruses of Microorganisms (ISVM).